{"pub": "marketwatch", "url": "https://marketwatch.com/story/bayer-backs-guidance-as-sales-rise-profit-falls-2019-10-30", "downloaded_at": "2019-10-30 07:54:22.823097+00:00", "title": "Bayer backs guidance as sales rise, profit falls", "language": "en", "text": "Germany\u2019s Bayer AG\u2019s said Wednesday that its third-quarter net profit fell while sales rose, and backed its guidance for the full year.\n\nNet profit for the period fell more than 60% to 1.04 billion euros ($1.15 billion) from EUR2.87 billion the same quarter last year when it had a large divestment gain, the chemical and pharmaceutical company BAYN, -0.44% said.\n\nSales increased to EUR9.83 billion from EUR9.26 billion a year earlier.\n\nThe company\u2019s earnings before interest, taxes, depreciation and amortization before special items rose 7.5% to EUR2.29 billion.\n\nAnalysts forecasted an Ebitda before special items of EUR2.36 billion and sales of EUR9.70 billion for Bayer, according to a consensus provided by Factset.\n\nThe company backed its outlook for the year, but adjusted figures to exclude its animal health business and its stake in Currenta, both of which it has agreed to sell. It expects sales of around EUR43.5 billion and Ebitda before special items to be around EUR11.5 billion.\n\nAs of Oct. 11, the company faces lawsuits from around 42,700 plaintiffs in cases relating to its subsidiary Monsanto\u2019s Roundup weedkiller, up from around 18,400 in July.", "description": "The company backed its outlook for the year, but adjusted figures to exclude its animal health business and its stake in Currenta, both of which it has...", "authors": ["Kim Richters"], "top_image": "http://s.marketwatch.com/public/resources/MWimages/MW-HJ473_Bayer__ZG_20190513172513.jpg", "published_at": "2019-10-30"}